Updated Drug Shortage Information for July 30, 2024

Jul 302024
 

Shortage updates July 30, 2024 Bupivacaine Hydrochloride Injection (Currently in Shortage) Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (Currently in Shortage) Carboplatin Injection (Currently in Shortage) Clindamycin Phosphate Injection (Currently in

Updated Drug Shortage Information for July 25, 2024

Jul 252024
 

Shortage updates July 25, 2024 Cefotaxime Sodium Injection (Currently in Shortage) Chloroprocaine Hydrochloride Injection (Currently in Shortage) Lorazepam Injection (Currently in Shortage) Midazolam Hydrochloride Injection (Currently in Shortage) Promethazine

FDA Drug Safety Information for July 24, 2024

Jul 242024
 

Date Brand Name(s) Description Type Reason Company  7/24/2024 Healthy Living Migraine Relief Acetaminophen 250mg, Aspirin (NSAID) 250mg & Caffeine 65mg tablets Drugs Device & Drug

Updated Drug Shortage Information for July 23, 2024

Jul 232024
 

Shortage updates July 23, 2024 Atropine Sulfate Injection (Currently in Shortage) Azacitidine Injection (Currently in Shortage) Carboplatin Injection (Currently in Shortage) Clonazepam Tablet (Currently in Shortage) Dexmedetomidine Hydrochloride Injection (Currently

FDA Drug Safety Information for July 22, 2024

Jul 222024
 

Date Brand Name(s) Description Type Reason Company  7/22/2024 Hikma Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL) 100 mL Drugs Potential presence of Dexmedetomidine

Updated Drug Shortage Information for July 22, 2024

Jul 222024
 

New shortages July 22, 2024 Dacarbazine Injection (Currently in Shortage) Posaconazole Tablet, Delayed Release (Discontinuation) Shortage updates July 22, 2024 Cyclopentolate Hydrochloride Ophthalmic Solution (Currently in Shortage) Hydroxypropyl

Updated Drug Shortage Information for July 18, 2024

Jul 182024
 

Shortage updates July 18, 2024 Bumetanide Injection (Currently in Shortage) Lisdexamfetamine Dimesylate Tablet, Chewable (Currently in Shortage) Sodium Phosphate, Dibasic, Anhydrous, Sodium Phosphate, Monobasic, Monohydrate Injection (Currently in

FDA Drug Safety Information for July 17, 2024

Jul 172024
 

Date Brand Name(s) Description Type Reason Company  7/17/2024 Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets Drugs Mislabeled with the incorrect strength

 Older Entries  Newer Entries